Who
John G. McHutchison
Director
Company insider
Files Form 4 as: Chief Executive Officer, Assembly Biosciences; Director, Metacrine; Chief Scientific Off/HeadR&D, Gilead Sciences.
In numbers
- Trades disclosed
- 38
- Buys
- 0
- Sells
- 9
- Bought
- $0
- Sold
- $439K
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 8 May 2018
- Last trade
- 4 Jun 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Jun 2026filed 5 Jun 2026 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 4 Jun 2026filed 5 Jun 2026 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,500 at $0.00 | filing |
| 31 Mar 2025filed 15 Apr 2025 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $7,456757 at $9.85 | filing |
| 29 May 2024filed 30 May 2024 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,750 at $0.00 | filing |
| 23 May 2024filed 24 May 2024 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $32K2,117 at $14.93 | filing |
| 1 Apr 2024filed 2 Apr 2024 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $16K1,206 at $13.07 | filing |
| 25 May 2023filed 30 May 2023 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 23 May 2023filed 24 May 2023 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $27K25,972 at $1.04 | filing |
| 22 May 2023filed 24 May 2023 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —117,500 at $0.00 | filing |
| 30 Mar 2023filed 31 Mar 2023 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $12K14,883 at $0.82 | filing |
| 8 Aug 2022filed 10 Aug 2022 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $26K12,314 at $2.13 | filing |
| 18 May 2022filed 6 Sep 2022 | Metacrineoption or derivative | SEC FORM 4 Code A | —16,500 at $0.00 | filing |
| 30 Mar 2022filed 31 Mar 2022 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $10K4,614 at $2.17 | filing |
| 29 Mar 2022filed 31 Mar 2022 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —335,000 at $0.00 | filing |
| 29 Mar 2022filed 31 Mar 2022 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —83,750 at $0.00 | filing |
| 29 Mar 2022filed 31 Mar 2022 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —83,750 at $0.00 | filing |
| 9 Aug 2021filed 10 Aug 2021 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $44K12,156 at $3.60 | filing |
| 24 May 2021filed 25 May 2021 | Metacrineoption or derivative | SEC FORM 4 Code A | —16,500 at $0.00 | filing |
| 29 Mar 2021filed 2 Apr 2021 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —305,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.